Beta Bionics (BBNX) Assets Average (2025 - 2026)
Beta Bionics' (BBNX) quarterly Assets Average came in at $316.6 million in Q1 2026, up 29.83% year-on-year from $243.8 million in Q1 2025, and down 3.89% quarter-over-quarter from $329.4 million in Q4 2025.
Beta Bionics (BBNX) Assets Average (2025 - 2026) Analysis & Trends
Beta Bionics has disclosed Assets Average across 2 years of filings, most recently posting $316.6 million for Q1 2026.
- Assets Average for Q1 2026 came in at $316.6 million, up 29.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $316.6 million (up 29.83% YoY), and the FY2025 annual result was $239.2 million, up 84.22% from the prior year.
- Assets Average came in at $316.6 million for Q1 2026 at Beta Bionics, down from $329.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $334.0 million in Q2 2025 to a low of $243.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.42 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.64 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.49 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.66 Bn |
| 10 | Beta Bionics | 617.66 Mn | 587.36 Mn | 16.44 Mn | 316.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316.58 Mn |
| Dec 31, 2025 | 329.39 Mn |
| Sep 30, 2025 | 330.01 Mn |
| Jun 30, 2025 | 334.00 Mn |
| Mar 31, 2025 | 243.83 Mn |